Xue‐Yan He

4.3k total citations · 2 hit papers
51 papers, 1.7k citations indexed

About

Xue‐Yan He is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xue‐Yan He has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 18 papers in Oncology and 18 papers in Immunology. Recurrent topics in Xue‐Yan He's work include Immune cells in cancer (9 papers), Immunotherapy and Immune Responses (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers). Xue‐Yan He is often cited by papers focused on Immune cells in cancer (9 papers), Immunotherapy and Immune Responses (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers). Xue‐Yan He collaborates with scholars based in China, United States and United Kingdom. Xue‐Yan He's co-authors include Mikala Egeblad, José M. Adrover, David L. Spector, Christopher R. Vakoc, Sheri A. C. McDowell, Daniela F. Quail, David Ng, Xiaoli Wu, Suling Liu and John E. Wilkinson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Xue‐Yan He

50 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps

2023 164 citations Xue‐Yan He, Mikala Egeblad et al. Cancer Cell profile →
Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment

2024 121 citations Xue‐Yan He, David Ng et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xue‐Yan He China	20	730	676	559	243	190	51	1.7k
Deborah S. Barkauskas United States	17	552 0.8×	815 1.2×	771 1.4×	140 0.6×	86 0.5×	34	1.9k
Rebecca A. Evans United States	18	468 0.6×	1.2k 1.8×	697 1.2×	183 0.8×	119 0.6×	26	1.9k
Maurizio Gelati Italy	23	780 1.1×	471 0.7×	403 0.7×	226 0.9×	76 0.4×	57	1.7k
Marta Mellai Italy	26	910 1.2×	346 0.5×	246 0.4×	411 1.7×	124 0.7×	57	1.8k
Klaudyna Kojder Poland	12	373 0.5×	330 0.5×	359 0.6×	227 0.9×	76 0.4×	29	1.2k
Carsten Hagemann Germany	26	1.1k 1.5×	404 0.6×	237 0.4×	419 1.7×	115 0.6×	74	2.0k
Chung Kwon Kim South Korea	20	584 0.8×	523 0.8×	360 0.6×	153 0.6×	60 0.3×	39	1.3k
Giuseppe Lamorte Italy	22	1.5k 2.0×	804 1.2×	245 0.4×	441 1.8×	148 0.8×	44	2.5k

Countries citing papers authored by Xue‐Yan He

Since Specialization

Citations

This map shows the geographic impact of Xue‐Yan He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue‐Yan He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue‐Yan He more than expected).

Fields of papers citing papers by Xue‐Yan He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue‐Yan He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue‐Yan He. The network helps show where Xue‐Yan He may publish in the future.

Co-authorship network of co-authors of Xue‐Yan He

This figure shows the co-authorship network connecting the top 25 collaborators of Xue‐Yan He. A scholar is included among the top collaborators of Xue‐Yan He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue‐Yan He. Xue‐Yan He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Wei, et al.. (2025). Orphan Class A GPCRs Signature Predicts Prognosis and Immune Microenvironment in Gastric Cancer: GPR176 Drives Tumor Progression Through Wnt Signaling and Macrophage Polarization. Mediators of Inflammation. 2025(1). 7977933–7977933. 2 indexed citations

Maia-Silva, Diogo, Damianos Skopelitis, Yuan Gao, et al.. (2024). Interaction between MED12 and ΔNp63 activates basal identity in pancreatic ductal adenocarcinoma. Nature Genetics. 56(7). 1377–1385. 6 indexed citations

Deng, Qiaodan, Cuicui Liu, Juchuanli Tu, et al.. (2024). SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1‐Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC. Advanced Science. 11(29). e2306860–e2306860. 1 indexed citations

Peng, Bo, Xue‐Yan He, Chunjuan Wang, et al.. (2024). Ratio-fluorescence detection of tert-butylhydroquinone based on non-conjugated polymer dots and gold nanoclusters. Food Chemistry. 444. 138624–138624. 6 indexed citations

Gao, Yuan, Xue‐Yan He, Xiaoli Wu, et al.. (2023). ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation. Nature Cell Biology. 25(2). 298–308. 19 indexed citations

Zhang, Rui, Mengxue Dong, Juchuanli Tu, et al.. (2023). PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway. Signal Transduction and Targeted Therapy. 8(1). 97–97. 68 indexed citations

Wu, Xiaoli, Xue‐Yan He, Jonathan J. Ipsaro, et al.. (2022). OCA-T1 and OCA-T2 are coactivators of POU2F3 in the tuft cell lineage. Nature. 607(7917). 169–175. 48 indexed citations

Sheng, Dandan, W. F. Mader, Rui Zhang, et al.. (2022). Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization. Journal for ImmunoTherapy of Cancer. 10(5). e003793–e003793. 51 indexed citations

Tu, Juchuanli, Xue‐Yan He, Bingjie Liu, et al.. (2022). Discovery of a first-in-class ANXA3 degrader for the treatment of triple-negative breast cancer. Acta Pharmaceutica Sinica B. 13(4). 1686–1698. 5 indexed citations

10.

Xu, Jiahui, Qiaodan Deng, W. F. Mader, et al.. (2021). Knockdown of Oligosaccharyltransferase Subunit Ribophorin 1 Induces Endoplasmic-Reticulum-Stress-Dependent Cell Apoptosis in Breast Cancer. Frontiers in Oncology. 11. 722624–722624. 29 indexed citations

11.

Lü, Yi, Xue‐Yan He, Chao Zhong, et al.. (2020). Vertical nanopillar induces deformation of cancer cell and alteration of ATF3 expression. Applied Materials Today. 20. 100753–100753. 6 indexed citations

12.

Fein, Miriam R., Xue‐Yan He, Ana S. Almeida, et al.. (2020). Cancer cell CCR2 orchestrates suppression of the adaptive immune response. The Journal of Experimental Medicine. 217(10). 45 indexed citations

13.

Liu, Bingjie, Qiaodan Deng, Dandan Sheng, et al.. (2020). UCP1 regulates ALDH-positive breast cancer stem cells through releasing the suppression of Snail on FBP1. Cell Biology and Toxicology. 37(2). 277–291. 16 indexed citations

14.

Zhou, Lei, Dong Wang, Dandan Sheng, et al.. (2020). NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer. Theranostics. 10(5). 2405–2421. 60 indexed citations

15.

Somerville, Tim D.D., Giulia Biffi, Juliane Daßler‐Plenker, et al.. (2020). Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation. eLife. 9. 58 indexed citations

16.

He, Xue‐Yan, David Ng, Linda Van Aelst, & Mikala Egeblad. (2019). Stressing Out about Cancer Immunotherapy. Cancer Cell. 36(5). 468–470. 10 indexed citations

17.

Chen, Weilong, Yuanyuan Qin, Dong Wang, et al.. (2018). CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer. PLoS Biology. 16(7). e2005869–e2005869. 70 indexed citations

18.

Ge, Hua, Yan Yan, Lingfei Guo, Xue‐Yan He, & Xianzhi Yang. (2017). Prognostic and clinical significance of VEGFR-3 in gastric cancer: A meta-analysis. Clinica Chimica Acta. 474. 114–119. 6 indexed citations

19.

Chen, Jiang, Yinan Du, Xue‐Yan He, Xingxu Huang, & Yun Stone Shi. (2017). A Convenient Cas9-based Conditional Knockout Strategy for Simultaneously Targeting Multiple Genes in Mouse. Scientific Reports. 7(1). 517–517. 17 indexed citations

20.

Peng, Yajing, Wei He, Jing Tang, et al.. (2010). Trio Is a Key Guanine Nucleotide Exchange Factor Coordinating Regulation of the Migration and Morphogenesis of Granule Cells in the Developing Cerebellum. Journal of Biological Chemistry. 285(32). 24834–24844. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact